The latest closing stock price for Monte Rosa Therapeutics as of January 21, 2025 is 5.69.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-731 today, roughly -1 times their original investment - a -28.01% compound annual growth rate over 4 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 117.9% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 3.21, which is 43.6% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.91.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-731 today, roughly -1 times their original investment - a -28.01% compound annual growth rate over 4 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 117.9% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 3.21, which is 43.6% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.91.